Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Beggs

Showing results (31-40 of 407) with videos related to

Pageof 41
Sort By:
The Journal of Antimicrobial Chemotherapy|July 1, 1994
Comparative activities of miconazole and the anticancer drug tamoxifen against Candida albicansW H Beggs
Antimicrobial Agents and Chemotherapy|February 1, 1994
Physicochemical cell damage in relation to lethal amphotericin B actionW H Beggs
Research Communications in Chemical Pathology and Pharmacology|September 1, 1982
Influence of pH on ketoconazole activity against Candida parapsilosis and Candida albicansW H Beggs
Mycopathologia|August 1, 1988
Requirement for nonprotonated drug molecules in the direct lethal action of miconazole against Candida albicansW H Beggs
Current Opinion in Pediatrics|December 16, 1998
Molecular genetics of long-QT syndromeD Wattanasirichaigoon, A H Beggs
Trends in Molecular Medicine|August 23, 2001
Clinical and genetic heterogeneity in nemaline myopathy--a disease of skeletal muscle thin filamentsD Sanoudou, A H Beggs
Physiology (Bethesda, Md.)|September 23, 2006
Selenoproteins and their impact on human health through diverse physiological pathwaysBehzad Moghadaszadeh, Alan H Beggs
Diagnostic Microbiology and Infectious Disease|January 1, 1987
Exploitation of the direct cell damaging action of antifungal azolesW H Beggs, C E Hughes
Research Communications in Chemical Pathology and Pharmacology|August 1, 1980
Antioxidant-mediated increases in the antifungal activities of amphotericin B and its methyl ester derivativeW H Beggs, F A Andrews
Diagnostic Microbiology and Infectious Disease|January 1, 1986
Irrelevance of growth phase with respect to the Bay n 7133 and ICI 153,066 susceptibilities of Candida albicansW H Beggs, C E Hughes
Pageof 41

Showing results (31-40 of 407) with videos related to

Sort By:
Pageof 41
The Journal of Antimicrobial Chemotherapy|July 1, 1994
Comparative activities of miconazole and the anticancer drug tamoxifen against Candida albicansW H Beggs
Antimicrobial Agents and Chemotherapy|February 1, 1994
Physicochemical cell damage in relation to lethal amphotericin B actionW H Beggs
Research Communications in Chemical Pathology and Pharmacology|September 1, 1982
Influence of pH on ketoconazole activity against Candida parapsilosis and Candida albicansW H Beggs
Mycopathologia|August 1, 1988
Requirement for nonprotonated drug molecules in the direct lethal action of miconazole against Candida albicansW H Beggs
Current Opinion in Pediatrics|December 16, 1998
Molecular genetics of long-QT syndromeD Wattanasirichaigoon, A H Beggs
Trends in Molecular Medicine|August 23, 2001
Clinical and genetic heterogeneity in nemaline myopathy--a disease of skeletal muscle thin filamentsD Sanoudou, A H Beggs
Physiology (Bethesda, Md.)|September 23, 2006
Selenoproteins and their impact on human health through diverse physiological pathwaysBehzad Moghadaszadeh, Alan H Beggs
Diagnostic Microbiology and Infectious Disease|January 1, 1987
Exploitation of the direct cell damaging action of antifungal azolesW H Beggs, C E Hughes
Research Communications in Chemical Pathology and Pharmacology|August 1, 1980
Antioxidant-mediated increases in the antifungal activities of amphotericin B and its methyl ester derivativeW H Beggs, F A Andrews
Diagnostic Microbiology and Infectious Disease|January 1, 1986
Irrelevance of growth phase with respect to the Bay n 7133 and ICI 153,066 susceptibilities of Candida albicansW H Beggs, C E Hughes
Pageof 41